vimarsana.com
Home
Live Updates
Lunaphore and Abcam Announce Agreement for Primary Antibody Validation for Use on COMET, Combining Power of Trusted Antibody Provider With Superior Multiplex Capabilities : vimarsana.com
Lunaphore and Abcam Announce Agreement for Primary Antibody Validation for Use on COMET, Combining Power of Trusted Antibody Provider With Superior Multiplex Capabilities
Lunaphore, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, and abcam (NASDAQ: ABCM), a global life science company working together with researchers
Related Keywords
United States
,
Switzerland
,
American
,
Swiss
,
Irene Tamayo
,
Courtney Nicholson
,
Abcam Corporate Communications
,
Application Development Team Leader
,
Lunaphore Corporate Communications
,
American Association For Cancer Research
,
Nasdaq
,
Business Development
,
Chief Marketing Officer
,
Vice President Business Development
,
American Association
,
Cancer Research
,
Annual Meeting
,
Corporate Communications
,
Lunaphore
,
Webcam
,
Nnounce
,
Agreement
,
Primary
,
Ntibody
,
Validation
,
Comet
,
Combining
,
Tower
,
Rusted
,
Provider
,
Ith
,
Superior
,
Multiplex
,
Capabilities
,
vimarsana.com © 2020. All Rights Reserved.